rdf:type |
|
lifeskim:mentions |
umls-concept:C0004561,
umls-concept:C0008109,
umls-concept:C0026809,
umls-concept:C0039194,
umls-concept:C0205410,
umls-concept:C0542341,
umls-concept:C1514562,
umls-concept:C1539477,
umls-concept:C1705848,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-4-14
|
pubmed:abstractText |
The Fas receptor delivers signals crucial for lymphocyte apoptosis through its cytoplasmic death domain. Several Fas cytoplasmic-associated proteins have been reported and studied in cell lines. So far, only Fas-associated death domain protein (FADD), another death domain-containing molecule has been shown to be essential for Fas signals in vivo. FADD is thought to function by recruiting caspase-8 through its death-effector domain. To test whether FADD is sufficient to deliver Fas signals, we generated transgenic mice expressing a chimera comprised of the Fas extracellular domain and FADD death-effector domain. Expression of this protein in lymphocytes of Fas-deficient MRL-lpr/lpr mice completely diminishes their T cell but not their B cell abnormalities. These results suggest that FADD alone is sufficient for initiation of Fas signaling in primary T cells, but other pathways may operate in B cells.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/FADD protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fadd protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Fas-Associated Death Domain Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2766-74
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10072523-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:10072523-Animals,
pubmed-meshheading:10072523-Antigens, CD95,
pubmed-meshheading:10072523-B-Lymphocytes,
pubmed-meshheading:10072523-Carrier Proteins,
pubmed-meshheading:10072523-Fas-Associated Death Domain Protein,
pubmed-meshheading:10072523-Humans,
pubmed-meshheading:10072523-Immunoglobulin G,
pubmed-meshheading:10072523-Jurkat Cells,
pubmed-meshheading:10072523-Lymphocyte Activation,
pubmed-meshheading:10072523-Mice,
pubmed-meshheading:10072523-Mice, Inbred MRL lpr,
pubmed-meshheading:10072523-Mice, Transgenic,
pubmed-meshheading:10072523-Recombinant Fusion Proteins,
pubmed-meshheading:10072523-Splenomegaly,
pubmed-meshheading:10072523-T-Lymphocytes
|
pubmed:year |
1999
|
pubmed:articleTitle |
A tailless fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice.
|
pubmed:affiliation |
Department of Molecular and Cell Biology, Division of Immunology and Cancer Research Lab, University of California at Berkeley, Berkeley, CA 94720, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|